Search results
Merck to Buy Eye Drug Company Eyebiotech for Up to $3 Billion. It’s Doubling Down on Deals.
Barrons.com· 6 days agoThe pharmaceutical company agrees to buy eye drug company Eyebiotech for up to $3 billion as it...
Merck to buy eye drug developer for $1.3B
BioPharma Dive via Yahoo Finance· 6 days agoAn acquisition of EyeBio will hand Merck a treatment for diabetic macular edema and age-related macular degeneration that’s ready for pivotal testing.
Merck & Co. sees clear vision to new ophthalmology assets with $3B EyeBio buy
FierceBiotech· 6 days agoMerck & Co. is focusing in on eye diseases with the $3 billion acquisition of ophthalmology-focused Eyebiotech. Merck will take on a ...
Tech Hubs Sprout Innovation
New Jersey Business Magazine· 1 day ago“We are the cradle of the pharmaceutical industry, and we have great academic institutions and more scientists per square mile than any other state in...
MSD agrees to acquire EyeBio for up to $3bn
Pharmaceutical Technology via Yahoo Finance· 5 days agoEyeBio CEO and president Dr David Guyer... team has successfully assembled a pipeline of novel candidates with the potential to provide new treatment...
New Study Quantifies the Impact of Improved Clinical Trial Design Using Faro Health's Study Designer...
Digital Journal· 6 days ago"This study demonstrates...patient-centric, digital tool, it can reduce the cost, time and burden of conducting clinical studies. This empowers clinical teams to...Quantify ...
What do the 10 physician billionaires have in common? They're all self-made
Becker's ASC Review· 5 days agoTen U.S. physicians appeared on Forbes' 38th annual list of the world's richest people. While the physicians range from company founders to inventors, they are all varying ...
Markets News, June 3, 2024: Nasdaq Ticks Higher; Oil, Treasury Yields Tumble
Investopedia· 15 hours agoU.S. stocks were mixed Monday, with weak manufacturing and construction data, as well as falling oil...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days ago(alice.uribe@wsj.com) 1717 ET – Padraig McDonnell steps into a tough spot just a few weeks after becoming CEO at Agilent. The laboratory-supplies company...
Newsweek hosts panel on the future of Life Sciences at BIO Convention 2024
Newsweek· 5 days agoAfter an initial wave of interest during the coronavirus pandemic, the health care and ...
